Insulin Aspart
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 62 (13) , 1945-1981
- https://doi.org/10.2165/00003495-200262130-00014
Abstract
Insulin aspart, a rapid-acting human insulin analogue, provides more rapid absorption than regular human insulin after subcutaneous administration.Keywords
This publication has 54 references indexed in Scilit:
- Insulin GlargineDrugs, 2001
- Clinical Pharmacokinetics and Pharmacodynamics of Insulin AspartClinical Pharmacokinetics, 2001
- Symptomatic and counterregulatory hormonal responses to acute hypoglycaemia induced by insulin aspart and soluble human insulin in Type 1 diabetesDiabetes/Metabolism Research and Reviews, 2000
- Insulin LisproDrugs, 1997
- Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 AspExperimental and Clinical Endocrinology & Diabetes, 1997
- Time-action Profile of the Insulin Analogue B28AspDiabetic Medicine, 1996
- Consensus Guidelines for the Management of Insulin‐dependent (Type 1) DiabetesDiabetic Medicine, 1993
- Action Profile of the Rapid Acting Insulin Analogue: Human Insulin B28AspDiabetic Medicine, 1993
- In Vitro and In Vivo Potency of Insulin Analogues Designed for Clinical UseDiabetic Medicine, 1991
- Monomeric Insulins and Their Experimental and Clinical ImplicationsDiabetes Care, 1990